Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
NCT04801108 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-04-13
Summary
The purpose of this protocol is to perform a pilot prospective randomized controlled clinical trial to evaluate the potential role of lung fissure completion strategy (experimental intervention) in addition to endobronchial valve (EBV) placement (representing "standard-of-care") in select patients with severe COPD/emphysema and with evidence for \<95% fissure completion between adjacent lung lobes. In select patients, lung fissure completion strategy will be performed by either video-assisted thorascopic surgery (VATS)-guided or robotic-guided stapling along the lung fissures in an attempt to reduce collateral ventilation and determine whether or not this experimental strategy will improve outcome following subsequent EBV placement. EBV placement will follow successful VATS-guided or robotic-guided fissure stapling.
The study will enroll approximately 20 patients at BIDMC, and outcomes will focus on procedure-related complications, physiological measurements (ex., FEV1 by pulmonary function testing) and clinical symptoms (i.e., questionnaires). Patient will be followed for 3-month period, receiving usual standard of care during the 3 months of follow-up. The goal of this protocol is to determine if elimination of significant collateral lung ventilation between lung lobes is possible, and whether such strategy to eliminate collateral lung ventilation between lobes improves outcomes following subsequent EBV placement (i.e. promotes atelectasis of diseased lung segments) in the management of severe COPD/emphysema in appropriate candidates. For subjects in the medical management control group, upon completion of the 3-month F/U period, they will be eligible for EBV if they choose.
Conditions
- Emphysema or COPD
Interventions
- PROCEDURE
-
Robotic or VATS lobar fissure completion
The lobar fissure adjacent to the target lobe will be completed using a surgical stapler through robotic or video-assisted thoracic surgery.
- DEVICE
-
Endobronchial valves placement
Endobronchial valves will be placed in the target lobe after the fissure completion.
Sponsors & Collaborators
-
Pulmonx Corporation
collaborator INDUSTRY -
Beth Israel Deaconess Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2026-08-01
- Completion
- 2026-08-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study
NCT02025205 ·Status: COMPLETED ·Phase: NA
-
Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV
NCT04161235 ·Status: COMPLETED
-
Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)
NCT04559464 ·Status: COMPLETED ·Phase: NA
-
Endobronchial Valve in Patients With Heterogeneous Emphysema
NCT02823223 ·Status: UNKNOWN ·Phase: NA
-
Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema
NCT00825578 ·Status: COMPLETED ·Phase: PHASE3
-
The Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung
NCT01682018 ·Status: UNKNOWN ·Phase: NA
-
Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema
NCT04537182 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema
NCT01220908 ·Status: COMPLETED ·Phase: NA
-
Improvement of Cardiovascular Function After Bronchoscopic Lung Volume Reduction Using Endobronchial Valves
NCT04556942 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema
NCT00675454 ·Status: TERMINATED
-
Safety and Efficacy of Endobronchial Valve for Bronchoscopic Lung Volume Reduction Surgery: a Prospective Pilot Study
NCT06349174 ·Status: RECRUITING ·Phase: NA
-
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
NCT01520740 ·Status: TERMINATED ·Phase: PHASE4
-
Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT03349437 ·Status: COMPLETED ·Phase: NA
-
Endobronchial Valves in Moderate COPD
NCT01969734 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)
NCT01328899 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves.
NCT05396131 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema
NCT01421082 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation
NCT02140892 ·Status: UNKNOWN ·Phase: NA
-
Zephyr Valve Japan Post-Marketing Surveillance
NCT06332885 ·Status: RECRUITING
-
Cell Therapy Associated With Endobronchial Valve
NCT04018729 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ex-Vivo Lung Reconditioning
NCT02906436 ·Status: COMPLETED ·Phase: NA
-
Post Market Observational, Prospective, Multi-center Study
NCT01806636 ·Status: TERMINATED
-
Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease
NCT06956742 ·Status: RECRUITING ·Phase: NA
-
AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
NCT01460108 ·Status: UNKNOWN ·Phase: PHASE4